D-66014-001 Class II Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC. — Hauppauge, NY

FDA drug recall D-66014-001 was initiated by Amneal Pharmaceuticals Of New York, LLC. on Aug 17, 2013 and is designated Class II. Reason for recall: Failed dissolution specifications; 18 month CRT The recall status is terminated (terminated Jul 17, 2014). Affected quantity: 895 - 1000 count bottles.

Recall details

Product Type
Drugs
Report Date
Nov 13, 2013
Initiation Date
Aug 17, 2013
Termination Date
Jul 17, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
895 - 1000 count bottles

Product description

Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal PHARMACEUTICALS label, NDC 65162-212-11 --- Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Amneal Pharmaceuticals Glasgow, KY 42141

Reason for recall

Failed dissolution specifications; 18 month CRT

Distribution pattern

IL, NH, NJ, NY, OH, RI, TN

Code information

Batch/Lot HL50611, exp. 1/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-66014-001
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-66014-001. Report a data issue: hello@regdatalab.com.